Congress Materials - The Professional Society for Health Economics and Outcomes Research (ISPOR 2026)
2026 The Professional Society for Health Economics and Outcomes Research | May 17-20 | Philadelphia, PA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Comparative Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Therapy for Major Depressive Disorder: A Network Meta-Analysis
Andrew J. Cutler, Anaïs Lemyre, Qiaoyi Zhang, Carol Mao, Todor I. Totev, Marjolaine Gauthier-Loiselle, Yujie Wu, Jingyi Liu, Mahmoud Hashim, Madhav Namjoshi, John J. Sheehan, Dominic Pilon, Patrick Lefebvre, Antoine El Khoury, Leslie Citrome
This document will be available after May 18 2026
The Role of Safety and Tolerability in HTA Value Assessment: Evidence Requirements and Impact Across Key European Markets
Carol Mao, Antoine El Khoury, Nan Li, Jochen Fleischmann, Tetsuro Ito, Tom Nijhuis, Rachel Xinyun Zhu, Eduardo Ochoa, Christoph Glaetzer
This document will be available after May 18 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.